The latest update is out from Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ).
Recordati S.p.A. announced an update on its share buyback program, which aims to purchase shares for stock option and performance share plans for its management. The company executed transactions to buy 256,449 ordinary shares over a five-day period in February 2025, reflecting its strategic focus on enhancing shareholder value and supporting its incentive plans.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati is an international pharmaceutical group listed on the Italian Stock Exchange, with origins in a family pharmacy in Northern Italy in the 1920s. The company specializes in therapeutic options for specialty and general medicine drugs, as well as rare diseases, with operations spanning clinical development to marketing across 150 countries in the EMEA, Americas, and APAC regions.
YTD Price Performance: 6.13%
Average Trading Volume: 31,880
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: €11.08B
For a thorough assessment of REC stock, go to TipRanks’ Stock Analysis page.